| Literature DB >> 32781185 |
Bina Kassamali1, Nazgol-Sadat Haddadi2, Mehdi Rashighi2, Margaret Cavanaugh-Hussey1, Avery LaChance3.
Abstract
Year: 2020 PMID: 32781185 PMCID: PMC7414778 DOI: 10.1016/j.jaad.2020.08.016
Source DB: PubMed Journal: J Am Acad Dermatol ISSN: 0190-9622 Impact factor: 11.527
Fig 1States that have enacted statewide legislative or regulatory policy changes to temporarily expand access or remove barriers to telehealth services during the coronavirus disease 2019 pandemic. AK, Alaska; AL, Alabama; AR, Arkansas; AZ, Arizona; CA, California; CO, Colorado; CT, Connecticut; DC, District of Columbia; DE, Delaware; FL, Florida; GA, Georgia; HI, Hawaii; IA, Iowa; ID, Idaho; IL, Illinois; IN, Indiana; KS, Kansas; KY, Kentucky; LA, Louisiana; MA, Massachusetts; MD, Maryland; ME, Maine; MI, Michigan; MN, Minnesota; MO, Missouri; MS, Mississippi; MT, Montana; NC, North Carolina; ND, North Dakota; NE, Nebraska; NH, New Hampshire; NJ, New Jersey; NM, New Mexico; NV, Nevada; NY, New York; OH, Ohio; OK, Oklahoma; OR, Oregon; PA, Pennsylvania; RI, Rhode Island; SC, South Carolina; SD, South Dakota; TN, Tennessee; TX, Texas; UT, Utah; VA, Virginia; VT, Vermont; WA, Washington; WI, Wisconsin; WV, West Virginia; WY, Wyoming. ∗Private payer coverage already in place or optional.